The histone variant macroH2A suppresses melanoma progression through regulation of CDK8

Nature

Volumn 468, Issue 7327, 2010, Pages 1105-1111

  Kapoor, Avnish ^a   Goldberg, Matthew S ^a   Cumberland, Lara K ^a   Ratnakumar, Kajan ^a   Segura, Miguel F ^b   Emanuel, Patrick O ^a   Menendez, Silvia ^b   Vardabasso, Chiara ^a   LeRoy, Gary ^c   Vidal, Claudia I ^a,d   Polsky, David ^b   Osman, Iman ^b   Garcia, Benjamin A ^c   Hernando, Eva ^b   Bernstein, Emily ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c PRINCETON UNIVERSITY   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 8; HISTONE H2A;

CANCER; GENETIC ANALYSIS; MITOCHONDRIAL DNA; PHENOTYPE; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN; CONTROLLED STUDY; GENE EXPRESSION; GENE LOSS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 8; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HCT116 CELLS; HISTONES; HUMANS; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM METASTASIS; RATS; UP-REGULATION;

EID: 78650816688     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature09590     Document Type: Article

References (30)

1. Bernstein, E. & Hake, S. B. The nucleosome: a little variation goes a long way. Biochem. Cell Biol. 84, 505-517 (2006).
2. Sarma, K. & Reinberg, D. Histone variants meet their match. Nature Rev. Mol. Cell Biol. 6, 139-149 (2005).
3. Thambirajah, A. A., Li, A., Ishibashi, T. & Ausió, J. New developments in posttranslational modifications and functions of histone H2A variants. Biochem. Cell Biol. 87, 7-17 (2009).
4. Changolkar, L. N. et al. Developmental changes in histone macroH2A1-mediated gene regulation. Mol. Cell. Biol. 27, 2758-2764 (2007).
5. Buschbeck, M. et al.The histone variantmacroH2Aisanepigenetic regulator of key developmental genes. Nature Struct. Mol. Biol. 16, 1074-1079 (2009).
6. Gamble, M. J., Frizzell, K. M., Yang, C., Krishnakumar, R. & Kraus, W. L. The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev. 24, 21-32 (2010).
7. Firestein, R. et al.CDK8is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455, 547-551 (2008).
8. Morris, E. J. et al. E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 455, 552-556 (2008).
9. Pehrson, J. R.&Fried, V. A.MacroH2A, a core histone containing a large nonhistone region. Science 257, 1398-1400 (1992).
10. Pehrson, J. R., Costanzi, C. & Dharia, C. Developmental and tissue expression patterns of histone macroH2A1 subtypes. J. Cell. Biochem. 65, 107-113 (1997).
11. Costanzi, C. & Pehrson, J. R. MacroH2A2, a new member of the MacroH2A core histone family. J. Biol. Chem. 276, 21776-21784 (2001).
12. Costanzi, C. & Pehrson, J. R. Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 393, 599-601 (1998).
13. Zhang, R. et al. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 8, 19-30 (2005).
14. Bernstein, E. et al. A phosphorylated sub-population of the histone variant macroH2A1 is enriched during mitosis and excluded from the inactive X chromosome. Proc. Natl Acad. Sci. USA 105, 1533-1538 (2008).
15. Hua, S. et al. Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol. Syst. Biol. 4, 188 (2008).
16. Sporn, J. C. et al. Histone macroH2A isoforms predict the risk of lung cancer recurrence. Oncogene 28, 3423-3428 (2009).
17. Hocker, T. L., Singh, M. K. & Tsao, H. Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside. J. Invest. Dermatol. 128, 2575-2595 (2008).
18. Jemal, A. et al. Cancer Statistics, 2009. CA Cancer J. Clin. 59, 225-249 (2009).
19. Clark,W.H. Jr et al. Model predicting survival in stage I melanomabased on tumor progression. J. Natl Cancer Inst. 81, 1893-1904 (1989).
20. Fidler, I. J. Selection of successive tumor lines formetastasis. Nature242, 148-149 (1973).
21. Satyamoorthy, K. et al. Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 7, S35-S42 (1997).
22. Plazas-Mayorca, M. D. et al. One-pot shotgun quantitative mass spectrometry characterization of histones. J. Proteome Res. 8, 5367-5374 (2009).
23. Yancovitz, M. et al. Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma. J. Mol. Diagn. 9, 178-183 (2007).
24. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949-954 (2002).
25. Qian, F., Vaux, D. L. & Weissman, I. L. Expression of the integrin a4b1 onmelanoma cells caninhibit the invasivestage ofmetastasis formation. Cell 77,335-347(1994).
26. Ryu, B., Kim, D. S., Deluca, A. M. & Alani, R. M. Comprehensive expression profiling of tumor cell lines identifiesmolecular signatures of melanomaprogression. PLoS ONE 2, e594 (2007).
27. Knuesel, M. T., Meyer, K. D., Bernecky, C. & Taatjes, D. J. The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. Genes Dev. 23, 439-451 (2009).
28. Segura, M. F. et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc. Natl Acad. Sci. USA 106, 1814-1819 (2009).
29. Kumaki, Y., Oda, M. & Okano, M. QUMA: quantification tool for methylation analysis. Nucleic Acids Res. 36, W170-175 (2008).
30. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protocols 4, 44-57 (2009).